Projects funded by the NCN

Optimisation of biocompatible scaffolds combinig graphen and defined stem cell populations for tissue regeneration.

Call: SYMFONIA 3 , Panel: NZ4

Principal investigator: prof. Ewa Zuba-Surma

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Study on the mechanism of cancer cell growth inhibition by synergistic activation of p53 protein caused by combined trea...

Call: OPUS 6 , Panel: NZ5

Principal investigator: dr hab. Marek Rusin

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Combined stem cell-based and gene therapy as a novel strategy to protect photoreceptors - evaluation of renewal mechanis...

Call: OPUS 4 , Panel: NZ5

Principal investigator: prof. Bogusław Machaliński

Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarski z Oddziałem Nauczania w Języku Angielskim

Combined effect of gene polymorphisms related to oxydative stress on the extent of atherosclerosis in coronary arteries ...

Call: PRELUDIUM 4 , Panel: NZ5

Principal investigator: dr Milena Racis

Gdański Uniwersytet Medyczny, Wydział Lekarski

The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance...

Call: PRELUDIUM 3 , Panel: NZ5

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

Impact of combined therapy of non-steroidal anti-inflammatory drugs and selective serotonin reuptake inhibitors on oxida...

Call: OPUS 3 , Panel: NZ5

Principal investigator: dr hab. Piotr Gałecki

Uniwersytet Medyczny w Łodzi, Wydział Wojskowo-Lekarski, Klinika Psychiatrii Dorosłych

Search for novel genes involved in pathogenesis of combied pituitary hormone deficiency

Call: HARMONIA 2 , Panel: NZ5

Principal investigator: dr Bartłomiej Budny

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

Combined induction of cell death of canine leukemia and lymphoma.

Call: OPUS 2 , Panel: NZ5

Principal investigator: dr hab. Andrzej Rapak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

Identification of novel genetic factors involved in congenital disorders of endocrine gland using advanced methods of ge...

Call: SONATA 2 , Panel: NZ5

Principal investigator: dr Bartłomiej Budny

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

Research on the raw sewage sludge transformation to hydrochar and lipids due to combined hydrothermal and biological tre...

Call: PRELUDIUM 22 , Panel: ST8

Principal investigator: Waheed Rasaq

Uniwersytet Przyrodniczy we Wrocławiu

Integrated approach 3M (Macrophytes-Microbiome-Modelling) to elucidate mechanisms of bioenergy production and micropollu...

Call: OPUS 22 , Panel: NZ9

Principal investigator: prof. Ewa Wojciechowska

Politechnika Gdańska, Wydział Inżynierii Lądowej i Środowiska

Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

Call: OPUS 19 , Panel: NZ7

Principal investigator: dr hab. Janusz Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

Metabolomic and proteomic studies combined with modern magnetic resonance imaging techniques to explore mechanisms of br...

Call: OPUS 19 , Panel: NZ5

Principal investigator: prof. Przemko Kwinta

Uniwersytet Jagielloński, Collegium Medicum

Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

Call: OPUS 19 , Panel: NZ7

Principal investigator: prof. Andrzej Pilc

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Development of new and more efficient treatment against mesothelioma utilizing oncolytic adenovirus armed with ICOS liga...

Call: SONATINA 3 , Panel: NZ7

Principal investigator: dr Łukasz Kuryk

Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny

STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

Call: OPUS 16 , Panel: NZ5

Principal investigator: dr hab. Ryszard Smolarczyk

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach

Genetically modified dendritic cells as a component of combined therapy immunomodulating the tumor microenvironment

Call: OPUS 14 , Panel: NZ6

Principal investigator: dr hab. Elżbieta Pajtasz-Piasecka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Combined urinary bladder cancer treatment with isothiocyanate-derived mercapturic acids and microtubule assembly modulat...

Call: SONATA 13 , Panel: NZ7

Principal investigator: dr Mateusz Psurski

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

The effect of Differential Speed Rolling processing combined with multi-variant heat treatment on structure and properti...

Call: SONATA 12 , Panel: ST8

Principal investigator: dr Wojciech Polkowski

Sieć Badawcza ŁUKASIEWICZ - Krakowski Instytut Technologiczny

New amide derivatives of cinnamic acid as a carbonyl reductase inhibitors, which modulate the activity of doxorubicin - ...

Call: SONATA 11 , Panel: NZ7

Principal investigator: dr Paulina Koczurkiewicz-Adamczyk

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny